Prostate CA Clinical Trials in Fuzhou, Fujian
19 recruitingFuzhou, Fujian, China
Showing 1–19 of 19 trials
Recruiting
Phase 2Phase 3
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Novartis Pharmaceuticals443 enrolled72 locationsNCT06780670
Recruiting
Phase 2
Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
First Affiliated Hospital of Fujian Medical University20 enrolled1 locationNCT07562438
Recruiting
Phase 3
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer600 enrolled233 locationsNCT06551324
Recruiting
Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC1,314 enrolled324 locationsNCT06136650
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled281 locationsNCT06925737
Recruiting
Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC1,310 enrolled282 locationsNCT06136624
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Celgene960 enrolled279 locationsNCT06764485
Recruiting
Phase 1Phase 2
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University6 enrolled1 locationNCT07363382
Recruiting
Phase 1Phase 2
Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
First Affiliated Hospital of Fujian Medical University9 enrolled1 locationNCT07363486
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 2Phase 3
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University100 enrolled1 locationNCT07209878
Recruiting
Phase 1Phase 2
68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University50 enrolled1 locationNCT07209865
Recruiting
Not Applicable
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
Prostate CancerSurgical Procedure, Unspecified
Ning Xu118 enrolled1 locationNCT06434649
Recruiting
Not Applicable
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
Prostate Cancer Screening
First Affiliated Hospital of Fujian Medical University230 enrolled1 locationNCT06923657
Recruiting
Phase 1Phase 2
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
First Affiliated Hospital of Fujian Medical University20 enrolled1 locationNCT07117760
Recruiting
Phase 1Phase 2
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
Prostate CA
First Affiliated Hospital of Fujian Medical University40 enrolled1 locationNCT07056790
Recruiting
Not Applicable
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Locally Advanced Prostate CancerRobotic-Assisted Radical ProstatectomyBladder Suspension
First Affiliated Hospital of Fujian Medical University300 enrolled1 locationNCT06977906
Recruiting
Phase 1Phase 2
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Prostate Cancer
Bivision Pharmaceuticals, Inc.90 enrolled13 locationsNCT06139575
Recruiting
Early Phase 1
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University10 enrolled1 locationNCT06612580